Glucosamine & Chondroitine & MSM
Natural health product licensed in Canada
- Other names
- Swical Glucosamine
- Licence holder
- Wampole Group L.P.
- NPN or DIN-HM
- 80001396
- Status
- Active licence
- Licence date
- 21 February 2006
- Revision date
- 15 September 2026
- Form
- Liquide
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
No point flagged by the rules we apply.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Poly-(1-3)-N-acetyl-2-amino-2-deoxy-3-0-B-D-glucopyranurosy-4-(and 6-)sulfonyl-D-galactose | 25 mg | Not calculated |
| Méthylsulfonylméthane | 75 mg | Not calculated |
| Sulfate de 2-amino-2-désoxy-D-glucose Source : Sulfate de glucosamine 2 chlorure de potassium provenant d'exosquelletes de crustacés | 1,500 mg | Not calculated |
Non-medicinal ingredients
Saveur d'orange, Sorbitol 70%, Glycérine, Eau purifiée, Glycyrrhizinate d'ammonium, Benzoate de sodium, Acid citrique, Colorant caramel, Saveur de vanille, Sorbate de potassium
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes | Not specified | 10 mL | 1 Tous les jours |
Uses authorised in Canada
Aide à soulager la douleur ostéoarthritique.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consulter un praticien de soins de santé si vous souffrez de maladie de coeur, si vous prenez un anti-arythmant ou un anticoagulant, si des douleurs gastrointestinales ou de la constipation surviennent ou si les symptômes persistent pour plus de 6 mois.
- Contre-indications
Ne pas utiliser en cas d'ulcères gastriques ou duodénal, grossesse et allaitement
Source
Official Health Canada record, licence 80001396
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
List in the official revision dated (register: Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks).
Has the product changed? Photograph the packaging.